Table 1. Clinical data and follow-up results of 16 patients with stage 4 NB.

Patient NO.	Age (month) /Age group	INPC	INSS	CNV	Event/ time of occurrence (month)	VGPR
2	72 (2)	UH	4	+	progress/15	NO
6	53 (2)	UH	4	+	progress /16	NO
8	40 (2)	UH	4	−	progress /18	NO
10	27 (2)	UH	4	+	none/35	YES
11	12 (1)	UH	4	+	death/17	NO
15	47 (2)	UH	4	−	none/19	YES
16	81 (2)	UH	4	−	progress /20	YES
17	71 (2)	UH	4	−	none/22	YES
19	67 (2)	UH	4	−	none/19	YES
20	57 (2)	FH	4	−	none/23	YES
22	39 (2)	UH	4	−	relapse /18	NO
26	52 (2)	UH	4	−	none/17	YES
30	62 (2)	UH	4	+	progress/13	NO
31	40 (2)	FH	4	−	progress/17	NO
32	42 (2)	FH	4	−	none/17	YES
33	36 (2)	UH	4	+	relapse /10	NO